|
Volumn 9, Issue 3, 2001, Pages 209-221
|
Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro
a a a a a a |
Author keywords
Blood brain barrier; Dalargin; Drug delivery; Nanoparticles
|
Indexed keywords
ALANINE DERIVATIVE;
AMINE OXIDASE (FLAVIN CONTAINING);
ARGININE DERIVATIVE;
BUFFER;
CYTOCHROME P450;
DEXTRAN;
ENBUCRILATE;
ENKEPHALIN DERIVATIVE;
FLUORESCEIN ISOTHIOCYANATE;
GLYCINE DERIVATIVE;
GLYCOPROTEIN P;
INULIN;
LEUCINE;
LEUCINE ENKEPHALIN[2 DEXTRO ALANINE 6 ARGININE];
LOPERAMIDE;
NANOPARTICLE;
NEUROTOXIN;
OPIATE;
PEPTIDE DERIVATIVE;
PHENYLALANINE DERIVATIVE;
PHOSPHATE;
POLY(BUTYLCYANOACRYLATE);
POLYSORBATE;
POLYSORBATE 80;
POTASSIUM DIHYDROGEN PHOSPHATE;
SODIUM CHLORIDE;
TRITIUM;
TUBOCURARINE CHLORIDE;
TYROSINE DERIVATIVE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
WATER;
ANALGESIA;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BLOOD BRAIN BARRIER;
BRAIN TISSUE;
CONTROLLED STUDY;
DRUG BRAIN LEVEL;
DRUG COATING;
DRUG SYNTHESIS;
DRUG TARGETING;
DRUG TRANSPORT;
EMULSION;
ENDOCYTOSIS;
ENDOTHELIUM CELL;
HYPOTHESIS;
IN VITRO STUDY;
IN VIVO STUDY;
MALE;
MOUSE;
NONHUMAN;
PHARMACOLOGICAL PARAMETERS;
POLYMERIZATION;
PRIORITY JOURNAL;
RADIOACTIVITY;
RAT;
STATISTICAL ANALYSIS;
TIGHT JUNCTION;
|
EID: 0034887157
PISSN: 1061186X
EISSN: None
Source Type: Journal
DOI: 10.3109/10611860108997929 Document Type: Article |
Times cited : (167)
|
References (28)
|